Quotes

Back To Menu

Tata India Pharma & Healthcare Fund (IDCW) RI Equity - Pharma
INVEST

Plan: OPEN | Option: Dividend | Meeta Shetty

25 Oct 24 | 12:00 AM

30.21 -0.16 (-0.52%)

  • Outperforms

    53.66%

    Return (1Y)

    beaten Nifty Pharma TRI by 16.08%

  • Less Volatile

    0.83%

    Standard Deviation (1Y)

    Lower Equity - Pharma by -0.11%

  • Inconsistent

    3/11

    Months

    Has underperformed Equity - Pharma

  • Value research rating

    Not Rated

Stock Composition

NAV

Critical Parameters

Everyone of us wants to create wealth by investing in top funds. Have a look at the key parameters that you need to check before deciding to invest in a mutual fund.

Returns

In last 1 year Tata India Pharma & Healthcare Fund (IDCW) RI, has underperformed by 16.08% (CAGR difference)

53.66%

Outperforms

This is Alpha

Performance Chart for Rs

Invested in

24 Nov 2023

Risk

In last 1 year , the volatility of Tata India Pharma & Healthcare Fund (IDCW) RI is Lower than by -0.11%

0.83%

Less Volatile

Risk Meter

Peer Comparison on Risk - Return

Consistency

For 3 out of Last 11 Months, i.e 27.27% of the times It underperformed its benchmark, Equity - Pharma

Consistency Meter

Outperforming Stocks Vs. Underperforming Stocks

Based on the last 1year analysis, currently there are, the benchmark the benchmark

View Stock Composition